Men and women from the STRIDE clinical trial: An assessment of stimulant abstinence symptom severity at residential treatment entry

Karen G. Chartier, Katherine Sanchez, Therese K. Killeen, Allison Burrow, Thomas Carmody, Tracy L. Greer, Madhukar H. Trivedi

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Background and Objectives: Gender-specific factors associated with stimulant abstinence severity were examined in a stimulant abusing or dependent residential treatment sample (N=302). Method Bivariate statistics tested gender differences in stimulant abstinence symptoms, measured by participant-reported experiences of early withdrawal. Multivariate linear regression examined gender and other predictors of stimulant abstinence symptom severity. Results: Women compared to men reported greater stimulant abstinence symptom severity. Anxiety disorders and individual anxiety-related abstinence symptoms accounted for this difference. African American race/ethnicity was predictive of lower stimulant abstinence severity. Discussion and Conclusions Women were more sensitive to anxiety-related stimulant withdrawal symptoms. Scientific Significance Clinics that address anxiety-related abstinence symptoms, which more commonly occur in women, may improve treatment outcome. (Am J Addict 2015;XX:XX-XX)

Original languageEnglish (US)
Pages (from-to)336-340
Number of pages5
JournalAmerican Journal on Addictions
Volume24
Issue number4
DOIs
StatePublished - Jun 1 2015

Fingerprint

Residential Treatment
Anxiety
Clinical Trials
Substance Withdrawal Syndrome
Anxiety Disorders
African Americans
Linear Models

Keywords

  • Anxiety
  • Early withdrawal symptoms
  • Gender
  • Stimulant abstinence severity

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Psychiatry and Mental health
  • Clinical Psychology

Cite this

Men and women from the STRIDE clinical trial : An assessment of stimulant abstinence symptom severity at residential treatment entry. / Chartier, Karen G.; Sanchez, Katherine; Killeen, Therese K.; Burrow, Allison; Carmody, Thomas; Greer, Tracy L.; Trivedi, Madhukar H.

In: American Journal on Addictions, Vol. 24, No. 4, 01.06.2015, p. 336-340.

Research output: Contribution to journalArticle

@article{868792182cc2466a9adf98f29f5b8bbd,
title = "Men and women from the STRIDE clinical trial: An assessment of stimulant abstinence symptom severity at residential treatment entry",
abstract = "Background and Objectives: Gender-specific factors associated with stimulant abstinence severity were examined in a stimulant abusing or dependent residential treatment sample (N=302). Method Bivariate statistics tested gender differences in stimulant abstinence symptoms, measured by participant-reported experiences of early withdrawal. Multivariate linear regression examined gender and other predictors of stimulant abstinence symptom severity. Results: Women compared to men reported greater stimulant abstinence symptom severity. Anxiety disorders and individual anxiety-related abstinence symptoms accounted for this difference. African American race/ethnicity was predictive of lower stimulant abstinence severity. Discussion and Conclusions Women were more sensitive to anxiety-related stimulant withdrawal symptoms. Scientific Significance Clinics that address anxiety-related abstinence symptoms, which more commonly occur in women, may improve treatment outcome. (Am J Addict 2015;XX:XX-XX)",
keywords = "Anxiety, Early withdrawal symptoms, Gender, Stimulant abstinence severity",
author = "Chartier, {Karen G.} and Katherine Sanchez and Killeen, {Therese K.} and Allison Burrow and Thomas Carmody and Greer, {Tracy L.} and Trivedi, {Madhukar H.}",
year = "2015",
month = "6",
day = "1",
doi = "10.1111/ajad.12190",
language = "English (US)",
volume = "24",
pages = "336--340",
journal = "American Journal on Addictions",
issn = "1055-0496",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - Men and women from the STRIDE clinical trial

T2 - An assessment of stimulant abstinence symptom severity at residential treatment entry

AU - Chartier, Karen G.

AU - Sanchez, Katherine

AU - Killeen, Therese K.

AU - Burrow, Allison

AU - Carmody, Thomas

AU - Greer, Tracy L.

AU - Trivedi, Madhukar H.

PY - 2015/6/1

Y1 - 2015/6/1

N2 - Background and Objectives: Gender-specific factors associated with stimulant abstinence severity were examined in a stimulant abusing or dependent residential treatment sample (N=302). Method Bivariate statistics tested gender differences in stimulant abstinence symptoms, measured by participant-reported experiences of early withdrawal. Multivariate linear regression examined gender and other predictors of stimulant abstinence symptom severity. Results: Women compared to men reported greater stimulant abstinence symptom severity. Anxiety disorders and individual anxiety-related abstinence symptoms accounted for this difference. African American race/ethnicity was predictive of lower stimulant abstinence severity. Discussion and Conclusions Women were more sensitive to anxiety-related stimulant withdrawal symptoms. Scientific Significance Clinics that address anxiety-related abstinence symptoms, which more commonly occur in women, may improve treatment outcome. (Am J Addict 2015;XX:XX-XX)

AB - Background and Objectives: Gender-specific factors associated with stimulant abstinence severity were examined in a stimulant abusing or dependent residential treatment sample (N=302). Method Bivariate statistics tested gender differences in stimulant abstinence symptoms, measured by participant-reported experiences of early withdrawal. Multivariate linear regression examined gender and other predictors of stimulant abstinence symptom severity. Results: Women compared to men reported greater stimulant abstinence symptom severity. Anxiety disorders and individual anxiety-related abstinence symptoms accounted for this difference. African American race/ethnicity was predictive of lower stimulant abstinence severity. Discussion and Conclusions Women were more sensitive to anxiety-related stimulant withdrawal symptoms. Scientific Significance Clinics that address anxiety-related abstinence symptoms, which more commonly occur in women, may improve treatment outcome. (Am J Addict 2015;XX:XX-XX)

KW - Anxiety

KW - Early withdrawal symptoms

KW - Gender

KW - Stimulant abstinence severity

UR - http://www.scopus.com/inward/record.url?scp=84929050476&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84929050476&partnerID=8YFLogxK

U2 - 10.1111/ajad.12190

DO - 10.1111/ajad.12190

M3 - Article

C2 - 25694201

AN - SCOPUS:84929050476

VL - 24

SP - 336

EP - 340

JO - American Journal on Addictions

JF - American Journal on Addictions

SN - 1055-0496

IS - 4

ER -